OBJECTIVE: The aim of the investigators was to develop a moderate intensity comprehensive behavioral treatment based on the principles of motivational interviewing and Cognitive Behavioral Therapy that, within the confines of a standardized abstinence-oriented treatment, would provide a broad spectrum of modules to assist those seeking treatment to achieve reduction of problematic drinking. METHOD: The core issue of how to deliver a flexible therapy tailored to the needs of individual clients while at the same time providing a standardized treatment protocol for a randomized clinical trial provided the dilemma out of which this unique standardized protocol arose. By using a single decision tree, client choice, combined with limited options, we were able to reconcile these conflicting demands. RESULTS: Key decisions that were made in developing the treatment protocol and the thinking leading to these decisions are described. CONCLUSIONS: Understanding these key issues and the factors that led to the decisions made will assist would-be users in their own clinical and/or clinical research needs.
RCT Entities:
OBJECTIVE: The aim of the investigators was to develop a moderate intensity comprehensive behavioral treatment based on the principles of motivational interviewing and Cognitive Behavioral Therapy that, within the confines of a standardized abstinence-oriented treatment, would provide a broad spectrum of modules to assist those seeking treatment to achieve reduction of problematic drinking. METHOD: The core issue of how to deliver a flexible therapy tailored to the needs of individual clients while at the same time providing a standardized treatment protocol for a randomized clinical trial provided the dilemma out of which this unique standardized protocol arose. By using a single decision tree, client choice, combined with limited options, we were able to reconcile these conflicting demands. RESULTS: Key decisions that were made in developing the treatment protocol and the thinking leading to these decisions are described. CONCLUSIONS: Understanding these key issues and the factors that led to the decisions made will assist would-be users in their own clinical and/or clinical research needs.
Authors: Ann L Anderson; Malcolm S Reid; Shou-Hua Li; Tyson Holmes; Lynn Shemanski; April Slee; Edwina V Smith; Roberta Kahn; Nora Chiang; Frank Vocci; Domenic Ciraulo; Charles Dackis; John D Roache; Ihsan M Salloum; Eugene Somoza; Harold C Urschel; Ahmed M Elkashef Journal: Drug Alcohol Depend Date: 2009-06-26 Impact factor: 4.492
Authors: John F Kelly; Sandra A Brown; Ana Abrantes; Christopher W Kahler; Mark Myers Journal: Alcohol Clin Exp Res Date: 2008-06-28 Impact factor: 3.455
Authors: Ralitza Gueorguieva; Ran Wu; Dennis Donovan; Bruce J Rounsaville; David Couper; John H Krystal; Stephanie S O'Malley Journal: Drug Alcohol Depend Date: 2009-12-06 Impact factor: 4.492
Authors: Molly Magill; Nadine R Mastroleo; Timothy R Apodaca; Nancy P Barnett; Suzanne M Colby; Peter M Monti Journal: J Subst Abuse Treat Date: 2010-12
Authors: Joseph S Locastro; Jennifer Sharpe Potter; Dennis M Donovan; David Couper; Kimberly W Pope Journal: J Stud Alcohol Drugs Date: 2008-11 Impact factor: 2.582
Authors: Richard Longabaugh; Philip W Wirtz; Suzy Bird Gulliver; Dena Davidson Journal: Psychopharmacology (Berl) Date: 2009-07-29 Impact factor: 4.530